- Home
- CVAC vs BAK Comparison
CVAC vs BAK Comparison
Compare CVAC & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVAC | BAK |
|---|---|---|
| Founded | 2000 | 1972 |
| Country | Germany | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CVAC | BAK |
|---|---|---|
| Price | $5.12 | $2.92 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $6.83 | $4.40 |
| AVG Volume (30 Days) | ★ 1.7M | 1.2M |
| Earning Date | 11-24-2025 | 11-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $83,000,117.00 | ★ $13,841,708,237.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.40 | $8.01 |
| P/E Ratio | $5.47 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $2.32 |
| 52 Week High | $5.72 | $5.26 |
Technical Indicators
Market Signals| Indicator | CVAC | BAK |
|---|---|---|
| Relative Strength Index (RSI) | 43.12 | 53.40 |
| Support Level | $5.11 | $2.82 |
| Resistance Level | $5.23 | $3.11 |
| Average True Range (ATR) | 0.13 | 0.15 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 30.83 | 24.42 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About BAK Braskem SA ADR
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.